(Q36622188)

15 August 2017

Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations (English)

1 reference

chronic lymphocytic leukemia

15 August 2017

0 references

1 reference

18

Chrysoula Belessi

1 reference

15 August 2017

22

Karin E Smedby

1 reference

15 August 2017

Karla Plevova

6

0 references

Paolo Ghia

Paolo Ghia

31

0 references

Livio Trentin

Livio Trentin

29

0 references

Gianluca Gaidano

24

Gianluca Gaidano

1 reference

15 August 2017

8

Panagiotis Baliakas

1 reference

15 August 2017

26

Frederic Davi

1 reference

15 August 2017

32

Kostas Stamatopoulos

1 reference

15 August 2017

23

David Oscier

1 reference

15 August 2017

Andreas Agathangelidis

13

Andreas Agathangelidis

1 reference

15 August 2017

10

Lesley-Ann Sutton

1 reference

15 August 2017

5

Larry Mansouri

1 reference

15 August 2017

17

Gunnar Juliusson

1 reference

15 August 2017

21

Anton W Langerak

1 reference

15 August 2017

19

Nicholas Chiorazzi

1 reference

15 August 2017

28

Jonathan C Strefford

1 reference

15 August 2017

7

Stavroula Ntoufa

1 reference

15 August 2017

12

Niki Stavroyianni

1 reference

15 August 2017

27

Christiane Pott

1 reference

15 August 2017

1

Viktor Ljungström

1 reference

15 August 2017

2

Diego Cortese

1 reference

15 August 2017

16

Jana Kotaskova

1 reference

15 August 2017

Emma Young

3

1 reference

15 August 2017

Tatjana Pandzic

4

1 reference

15 August 2017

Ruth Clifford

9

1 reference

15 August 2017

Stuart J Blakemore

11

1 reference

15 August 2017

Davide Rossi

14

1 reference

15 August 2017

Martin Höglund

15

1 reference

15 August 2017

Panagiotis Panagiotidis

20

1 reference

15 August 2017

Anna Schuh

25

1 reference

15 August 2017

Sarka Pospisilova

30

1 reference

15 August 2017

Tobias Sjöblom

33

1 reference

15 August 2017

Richard Rosenquist

34

1 reference

15 August 2017

language of work or name

English

0 references

publication date

16 December 2015

1 reference

15 August 2017

10

1 reference

based on heuristic

inferred from page(s)

published in

Blood

1 reference

15 August 2017

127

1 reference

15 August 2017

8

1 reference

15 August 2017

1007-1016

1 reference

describes a project that uses

15 August 2017

ImageQuant

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC4768426/fullTextXML

based on heuristic

inferred from PubMed Central ID database lookup

cites work

Mutations driving CLL and their evolution in progression and relapse

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

SciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolution

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

Recurrent mutations refine prognosis in chronic lymphocytic leukemia.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

Acquired initiating mutations in early hematopoietic cells of CLL patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

EXCAVATOR: detecting copy number variants from whole-exome sequencing data

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

Ribosomal proteins RPL37, RPS15 and RPS20 regulate the Mdm2-p53-MdmX network

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

The implications of clonal genome evolution for cancer medicine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

Evolution and impact of subclonal mutations in chronic lymphocytic leukemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

Inactivation of ribosomal protein L22 promotes transformation by induction of the stemness factor, Lin28B.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

Monitoring chronic lymphocytic leukemia progression by whole genome sequencing reveals heterogeneous clonal evolution patterns

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

SF3B1 and other novel cancer genes in chronic lymphocytic leukemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

A framework for variation discovery and genotyping using next-generation DNA sequencing data

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

Fast and accurate long-read alignment with Burrows-Wheeler transform

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

Assessment of fludarabine plus cyclophosphamide for patients with chronic lymphocytic leukaemia (the LRF CLL4 Trial): a randomised controlled trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

High-resolution genomic profiling of chronic lymphocytic leukemia reveals new recurrent genomic alterations

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4768426

10.1182/BLOOD-2015-10-674572

4 December 2018

Identifiers

DOI

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

26675346

1 reference